Activity of β-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis

Summary The increase of incidence of tuberculosis (TB) with resistant strains and HIV co-infection has reinforced the necessity of developing new drugs for its treatment. The reaction of naphthoquinones with aromatic or aliphatic aldehydes in the presence of ammonium acetate led to the synthesis of...

Full description

Saved in:
Bibliographic Details
Published in:Tuberculosis (Edinburgh, Scotland) Scotland), 2010-09, Vol.90 (5), p.293-297
Main Authors: Coelho, Tatiane S, Silva, Raphael S.F, Pinto, Antonio V, Pinto, Maria C.F.R, Scaini, Carlos J, Moura, Kelly C.G, Almeida da Silva, Pedro
Format: Article
Language:English
Subjects:
Activity antimicrobial
Antitubercular Agents - pharmacology
Cell Line
Drug Resistance, Microbial - drug effects
Humans
Infectious Disease
Microbial Sensitivity Tests
Mycobacterium tuberculosis - drug effects
Naphthoimidazoles
Naphthoquinones - pharmacology
Phenazines
Phenazines - pharmacology
Pulmonary/Respiratory
Rifampin - pharmacology
β-Lapachone
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary The increase of incidence of tuberculosis (TB) with resistant strains and HIV co-infection has reinforced the necessity of developing new drugs for its treatment. The reaction of naphthoquinones with aromatic or aliphatic aldehydes in the presence of ammonium acetate led to the synthesis of the three β-lapachone derivatives (naphthoimidazoles) that were tested in this study. Phenazines were prepared by the reaction of the respective naphtoquinone with o-phenylenediamine in acetic acid under reflux. The antimicrobial activity of the derivatives was evaluated in vitro against Mycobacterium tuberculosis H37Rv (ATCC 27294) and the rifampicin-resistant strain (ATCC 35338) containing a His-526-Tir mutation in the rpo B gene. Using the Resazurin Microtiter Assay (REMA) method, bioactive molecules were observed in the susceptible and resistant strains with MICs ranging from 2.2 μM to 17 μM. The naphthoimidazoles with p- toluyl and indolyl group attached to the imidazole ring were more active against the H37Rv strain (MIC 9.12 μM and 4.2 μM, respectively) than the rifampicin-resistant strain (MIC 8.3 μM and 17 μM, respectively). The phenazine with the allyl-pyran group was most active among the two strains and had an MIC of 2.2 μM. These results show the potential of these molecules as prototypes for future drugs used in treating TB.
ISSN:1472-9792
1873-281X
DOI:10.1016/j.tube.2010.06.001